INTRAOPERATIVE MITOMYCIN-C VERSUS BEVACIZUMAB ON SUCCESS RATE OF PHACOTRABECULECTOMY

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

PANAHIBAZAZ M.R.; ZAMANI M.; SHARIFIPOOR F.; KHOSHNOD S.; LATIFI M.

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: BINA Year:2011 | Volume:17 | Issue:1 (66) Page(s): 8-15

Download Full-Text

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

View:

718

Download:

Cites:

Information Journal Paper

Title

INTRAOPERATIVE MITOMYCIN-C VERSUS BEVACIZUMAB ON SUCCESS RATE OF PHACOTRABECULECTOMY

Author(s)

Keywords

BEVACIZUMABQ3

MITOMYCIN-CQ3

PHACOTRABECULECTOMYQ3

Abstract

Purpose: To compare the success rate of MITOMYCIN-C Versus BEVACIZUMAB for prevention of bleb failure following PHACOTRABECULECTOMY.Method: In this study 74 eyes of 69 patients with uncontrolled IOP, progressive visual field loss and cataract were randomized in two groups. In the first group, after conjunctival peritomy at the sclera flap site, sponge pats soaked in mitomycin C with concentration of 0.25 mg/ml were applied for 3 minutes. In the second group, BEVACIZUMAB with concentration of 1.25 mg/0.5 ml was injected adjacent to the bleb at the end of surgery.Result: Seventy four eyes of 69 patients including 41 men and 28 women with mean age of 66.92±9.8 years months after surgery were analyzed. Mean intraocular pressure in the BEVACIZUMAB group was significantly higher than the MMC group (15.91±4.9 mmHg vs 12.76±3.1 mmHg, P=0.001) at 6 months and (15.76±3.26 mmHg vs 13±2.4 mmHg, P=0.003) at the end of 12 months. Bleb characteristics including extension, elevation and vascularity showed no significant difference between two groups. (P values 0.94, 0.93, 0.41 after 6 months, and 0.56, 0.58, 0.89 after 1 year of follow up respectively).One eye in the second group underwent trabeculectomy because of uncontrolled IOP despite using 3 antiglaucoma medications. One eye in each group underwent bleb revision due to failing bleb. No sides effects related to the medications were noted in any of the two groups.Conclusion: Mitomycin C is more effective than BEVACIZUMAB for IOP control after PHACOTRABECULECTOMY; however, there is no difference between the two agents in terms of bleb characteristics and side effects.

Cites

No record.

References

No record.

Cite

APA: Copy

PANAHIBAZAZ, M.R., ZAMANI, M., SHARIFIPOOR, F., KHOSHNOD, S., & LATIFI, M.. (2011). INTRAOPERATIVE MITOMYCIN-C VERSUS BEVACIZUMAB ON SUCCESS RATE OF PHACOTRABECULECTOMY. BINA, 17(1 (66)), 8-15. SID. https://sid.ir/paper/42234/en

Vancouver: Copy

PANAHIBAZAZ M.R., ZAMANI M., SHARIFIPOOR F., KHOSHNOD S., LATIFI M.. INTRAOPERATIVE MITOMYCIN-C VERSUS BEVACIZUMAB ON SUCCESS RATE OF PHACOTRABECULECTOMY. BINA[Internet]. 2011;17(1 (66)):8-15. Available from: https://sid.ir/paper/42234/en

IEEE: Copy

M.R. PANAHIBAZAZ, M. ZAMANI, F. SHARIFIPOOR, S. KHOSHNOD, and M. LATIFI, “INTRAOPERATIVE MITOMYCIN-C VERSUS BEVACIZUMAB ON SUCCESS RATE OF PHACOTRABECULECTOMY,” BINA, vol. 17, no. 1 (66), pp. 8–15, 2011, [Online]. Available: https://sid.ir/paper/42234/en

Related Journal Papers